NCT02077361: An Open Label Clinical Trial of Retinal Gene Therapy for Choroideremia
- State
- Completed
- Phase
- Phase 1 and Phase 2
- People
- 6 taking part
- Started
- Apr 2015
- Primary completion
- 30 Aug 2017
- Arms
- Open Label
- Results
- None posted
- 4 Mar 2014: Trial registered
- 16 May 2022: Trial completed